There are a number of errors in Table 1. The "Application" value for "P38MAPK" in line 4 should read "WB". The "Dilution" value for "MAPKAPK2" in line 13 should read "1:1000(WB)". The "Dilution" value for "HSP27" in line 15 should read "1:1000". Please view the correct [Table 1](#pone.0172599.t001){ref-type="table"} here.
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###### Primary antibodies used for immunodetection.
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  Name        Species   Manufacturer     Product number   Application   Dilution
  ----------- --------- ---------------- ---------------- ------------- ----------------------
  pEGFR       Rabbit    Cell Signaling   3777             WB, IF        1:1000(WB),1:100(IF)
  EGFR        Rabbit    Cell Signaling   4267             WB, IF        1:1000(WB),1:100(IF)
  pP38MAPK    Rabbit    Cell Signaling   4511             WB, IF        1:1000(WB),1:100(IF)
  P38MAPK     Rabbit    Cell Signaling   9212             WB            1:1000
  pJNK        Rabbit    Cell Signaling   4668             WB            1:1000
  pJNK        Mouse     Cell Signaling   9255             IF            1:100
  JNK         Rabbit    Cell Signaling   9252             WB            1:1000
  pERK        Rabbit    Cell Signaling   4370             WB, IF        1:1000(WB),1:100(IF)
  ERK         Rabbit    Cell Signaling   9102             WB            1:1000
  p-c-Jun     Rabbit    Cell Signaling   3270             WB, IF        1:1000(WB),1:100(IF)
  c-Jun       Rabbit    Cell Signaling   9165             WB            1:1000
  pMAPKAPK2   Rabbit    Cell Signaling   3007             WB, IF        1:1000(WB),1:100(IF)
  MAPKAPK2    Rabbit    Cell Signaling   3042             WB            1:1000
  pHSP27      Rabbit    Cell Signaling   9709             WB, IF        1:1000(WB),1:100(IF)
  HSP27       Mouse     Cell Signaling   2402             WB            1:1000
  BrdU        Mouse     Proteintech      66241            IF            1:500

WB, Western blot; IF, immunofluorescence.

In Fig 5, Fig 5C shows the incorrect image under the "AF 1.0 μM" header for "0h". Please view the correct [Fig 5](#pone.0172599.g001){ref-type="fig"} here.

![Auranofin inhibits EGF-dependent proliferation and migration of ARPE-19 cells.\
(A) Immunofluorescence microphotographs of proliferating ARPE-19 cell with BrdU (red) and DAPI (blue) staining after ARPE-19 cells were untreated or treated with AF (1.0 μM) in the absence or presence of EGF (100ng/ml) for 24 hours and then subjected to BrdU labeling for 4 hours, followed by immunostaining with anti-BrdU antibody and DAPI. Scale bar = 20μm. (B) Quantitation data of the number of BrdU^+^ cells shown in panel A. (C) ARPE-19 cells were subjected to wound healing assay, and then were left untreated or treated with AF (1.0 μM) in the absence or presence of EGF (100 ng/ml) for 24 hours. Scale bar = 100μm. (D) Quantitation of the results shown in panel C. (E) ARPE-19 cells were treated with 1.0 μM AF for 6, 12 and 24 hours. Cell lysates were subjected to Western blot for determination of total and phosphorylated EGFR, P38MAPK, ERK and JNK proteins. β-actin was used as a loading control. (F) Quantitative data of Western blot results shown in panel E from three experiments. The levels of the phosphorylated protein were compared with the control, \* P \< 0.05, \*\* P \< 0.01. The levels of the total protein were compared with the control, ^※^P \< 0.05, ^※※^P \< 0.01. All data are mean ± SEM.](pone.0172599.g001){#pone.0172599.g001}
